HA
AVNR

Havens Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Havens Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-145,000
Closed -$2.46M – 54
2014
Q4 		$2.46M Buy
+145,000
New +$2.04M 1.53% 21

Havens Advisors's AVNR Position: Q1 2015 in Review

Havens Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 145,000 shares — an estimated $2.46M sold.

Havens Advisors first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $2.46M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Havens Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Havens Advisors sold 145,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.46M.
  • Havens Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Havens Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.46M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Havens Advisors's 13F filing for Q1 2015, filed 5 May 2015.